| Income statement (USD) | FY 2025 ended Dec 28, 2025 | FY 2024 ended Dec 29, 2024 | FY 2023 ended Dec 31, 2023 | FY 2022 ended Jan 1, 2023 | FY 2021 ended Jan 2, 2022 | FY 2020 ended Jan 3, 2021 |
|---|---|---|---|---|---|---|
| Revenue | 94.19B | 88.82B | 85.16B | 79.99B | 78.74B | 82.58B |
| Cost of revenue | 30.26B | 27.47B | 26.55B | 24.60B | 23.40B | 28.43B |
| Gross profit | 63.94B | 61.35B | 58.61B | 55.39B | 55.34B | 54.16B |
| Research and development | 109.00M | 1.84B | 483.00M | 0 | 0 | 12.16B |
| Selling, general and admin | 23.68B | 22.87B | 21.51B | 20.25B | 20.12B | 22.08B |
| Interest expense | 971.00M | 755.00M | 772.00M | 276.00M | 183.00M | 201.00M |
| Income before tax | 32.58B | 16.69B | 15.06B | 19.36B | 19.18B | 16.50B |
| Income tax | 5.78B | 2.62B | 1.74B | 2.99B | 1.38B | 1.78B |
| Net income | 26.80B | 14.07B | 35.15B | 17.94B | 20.88B | 14.71B |
| EPS | 11.13 | 5.84 | 13.88 | 6.83 | 7.93 | 5.59 |
| EPS (diluted) | 11.03 | 5.79 | 13.72 | 6.73 | 7.81 | 5.51 |
| Diluted shares | 2.43B | 2.43B | 2.56B | 2.66B | 2.67B | 2.67B |
| Dividends per share | 5.14 | 4.91 | 4.70 | 4.45 | 4.19 | 3.98 |
From Johnson & Johnson's 10-K and 10-Q filings with the SEC. Fiscal years are the company's own, so they may not match the calendar. A blank cell means the company did not report that line. New to this? Read income statement or reading a 10-K.
Revenue, earnings, margins and balance sheet trends drawn by TradingView from its own data, so figures can differ slightly from the SEC table above.